Refresh

Plethico Pharmaceuticals Ltd. - Research Center

532739 PLETHICO Group (Z) BSE data
Back to Company

Results

Statement

More

Profit & Loss Account
(Rs crore)
Mar ' 15 Mar ' 14 Dec ' 12 Dec ' 11 Dec ' 10
Income

Operating income

136.63 531.30 475.06 409.55 447.52
Expenses

Material consumed

80.87 418.42 403.74 261.60 233.94

Manufacturing expenses

- 7.28 6.98 10.84 9.37

Personnel expenses

26.75 33.70 28.92 35.40 31.09

Selling expenses

- - - 41.90 27.71

Adminstrative expenses

23.85 44.32 43.33 16.24 14.47

Expenses capitalised

- - - - -

Cost of sales

131.47 503.73 482.96 365.97 316.58

Operating profit

5.16 27.56 -7.90 43.58 130.94

Other recurring income

- 37.31 35.76 1.58 0.41

Adjusted PBDIT

- 64.87 27.86 45.16 131.35

Financial expenses

54.41 62.77 49.93 81.31 35.21

Depreciation

12.74 10.40 8.30 8.24 7.46

Other write offs

- - - 0.97 1.92

Adjusted PBT

-61.99 -8.29 -30.37 -45.36 86.76

Tax charges

-107.94 0.44 0.84 10.20 19.63

Adjusted PAT

45.95 -8.73 -31.21 -55.55 67.14

Non recurring items

-319.56 - 23.32 14.57 -11.27

Other non cash adjustments

- - - 3.34 2.04

Reported net profit

-273.61 -8.73 -7.89 -37.64 57.91

Earnigs before appropriation

-273.61 244.40 253.14 261.03 333.56

Equity dividend

- - - - 7.14

Preference dividend

- - - - -

Dividend tax

- - - - 1.38

Retained earnings

-273.61 244.40 253.14 261.03 325.05
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com